Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - roman spektor
Rapid method to design and screen novel lipid nanoparticles for mRNA delivery in vivo
A platform technology to rapidly identify novel lipid nanoparticle (LNP) formulations to carry mRNA-based therapeutics to target organs/cells in vivo.Problem: Messenger RNA (mRNA) has emerged as a promising new class of nucleic acid therapy, with the potential to induce protein production to treat and prevent a range of diseases. While significant progress...
Chemical Processes and Synthesis
Research Tools & Reagents
Therapeutics & Vaccines
© 2020. All Rights Reserved. Powered by